NO952234L - Transdermal administration system containing acetylsalicylic acid for antithrombosis therapy and cancer prevention - Google Patents

Transdermal administration system containing acetylsalicylic acid for antithrombosis therapy and cancer prevention

Info

Publication number
NO952234L
NO952234L NO952234A NO952234A NO952234L NO 952234 L NO952234 L NO 952234L NO 952234 A NO952234 A NO 952234A NO 952234 A NO952234 A NO 952234A NO 952234 L NO952234 L NO 952234L
Authority
NO
Norway
Prior art keywords
therapy
transdermal administration
acetylsalicylic acid
antithrombosis
administration system
Prior art date
Application number
NO952234A
Other languages
Norwegian (no)
Other versions
NO952234D0 (en
Inventor
Frank Becher
Thomas Kissel
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4241128A external-priority patent/DE4241128C2/en
Priority claimed from PCT/EP1993/003231 external-priority patent/WO1994013302A1/en
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO952234D0 publication Critical patent/NO952234D0/en
Publication of NO952234L publication Critical patent/NO952234L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen vedrører et transdermalt admnistreringssytem for antitrombotisk terapi henholdsvis for profylakse mot kreft, hvilket som virkestoff inneholder acetylsalicylsyre og/eller farmasøytisk akseptable salter derav.The invention relates to a transdermal administration system for antithrombotic therapy and for prophylaxis of cancer, respectively, which contains as active ingredient acetylsalicylic acid and / or pharmaceutically acceptable salts thereof.

NO952234A 1992-12-07 1995-06-06 Transdermal administration system containing acetylsalicylic acid for antithrombosis therapy and cancer prevention NO952234L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4241128A DE4241128C2 (en) 1991-12-20 1992-12-07 Use of a transdermal administration system which contains acetylsalicylic acid and / or pharmaceutically acceptable salts thereof as active ingredient
PCT/EP1993/003231 WO1994013302A1 (en) 1991-12-20 1993-11-18 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer

Publications (2)

Publication Number Publication Date
NO952234D0 NO952234D0 (en) 1995-06-06
NO952234L true NO952234L (en) 1995-06-06

Family

ID=6474576

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952234A NO952234L (en) 1992-12-07 1995-06-06 Transdermal administration system containing acetylsalicylic acid for antithrombosis therapy and cancer prevention

Country Status (14)

Country Link
EP (1) EP0671916A1 (en)
JP (1) JP3799502B2 (en)
AU (1) AU694410B2 (en)
CA (1) CA2150033A1 (en)
CZ (1) CZ149495A3 (en)
FI (1) FI120719B (en)
HR (1) HRP931474A2 (en)
HU (1) HUT75680A (en)
IL (1) IL107867A (en)
NO (1) NO952234L (en)
NZ (1) NZ258129A (en)
PL (1) PL174770B1 (en)
SK (1) SK75495A3 (en)
ZA (1) ZA939126B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050111317A (en) * 2003-01-23 2005-11-24 샤이어 홀딩스 아게 Formulation and methods for the treatment of thrombocythemia
BRPI0418546A (en) 2004-02-16 2007-05-22 Teikoku Seiyaku Kk external preparation for treatment of painful skin wound
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
JP6720257B2 (en) * 2018-09-05 2020-07-08 テックフィールズ インコーポレイテッド NSAIA prodrugs with very fast skin and membrane penetration rates and novel pharmaceutical uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2496459A1 (en) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P PHARMACEUTICAL COMPOSITION IN THE FORM OF A GEL CONTAINING ACETYLSALICYLIC ACID
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
HRP921157A2 (en) * 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy

Also Published As

Publication number Publication date
JPH08504198A (en) 1996-05-07
PL309285A1 (en) 1995-10-02
CZ149495A3 (en) 1996-03-13
NZ258129A (en) 1999-10-28
AU694410B2 (en) 1998-07-23
ZA939126B (en) 1994-08-05
NO952234D0 (en) 1995-06-06
FI952805A0 (en) 1995-06-07
FI952805A (en) 1995-06-07
IL107867A (en) 1998-08-16
SK75495A3 (en) 1996-05-08
JP3799502B2 (en) 2006-07-19
HRP931474A2 (en) 1994-12-31
IL107867A0 (en) 1994-04-12
CA2150033A1 (en) 1994-06-23
HUT75680A (en) 1997-05-28
FI120719B (en) 2010-02-15
EP0671916A1 (en) 1995-09-20
PL174770B1 (en) 1998-09-30
HU9501641D0 (en) 1995-08-28
AU5563294A (en) 1994-07-04

Similar Documents

Publication Publication Date Title
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
CZ158695A3 (en) Pyrazolopyrimidine compounds as such and for treating diseases and pharmaceutical preparations based thereon
TW234691B (en)
ES2061252T3 (en) ANTITUSIVE AGENT AND REGULATOR OF THE MUCOSA, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
AU4180593A (en) The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
ATE282418T1 (en) ORAL ADMINISTRATION OF EFFECTIVE AMOUNTS OF HYALURONIC ACID
IS4923A (en) Treatment plans for administration of H +, K + -ATPase blockers
NO924723D0 (en) PHARMACOLOGICAL USE OF CERTAIN CYSTIN DERIVATIVES
DK515489A (en) DISPERSIBLE MEDICINAL FORMULATION
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
NO952234L (en) Transdermal administration system containing acetylsalicylic acid for antithrombosis therapy and cancer prevention
NO884176D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMIDINO DERIVATIVES.
HUP9901659A2 (en) Use of flupirtin for producing pharmaceutical compositions suitable for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system
NO891114L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARAKIDONIC ACID DERIVATIVES.
LT96093A (en) The active ingredient of pharmaceutical composition for treating aphtae and stomatitis
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
AU6970394A (en) Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2
ES469020A1 (en) N1-acyl-N2-phenyldiaminopropanols and pharmaceutical compositions thereof
NO990283L (en) Formulation for the treatment and / or prophylaxis of dementia
DK192487D0 (en) CARBIOVASCULAR PHARMACEUTICAL PREPARATIONS SUITABLE FOR TOPIC ADMINISTRATION
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
NO863005D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,4,5,6,7,8-HEXSAHYDRO-2-ALKYL-4-ARYL-5-OXO-1,7-NAFTYRIDINE-3-CARBOXYL ACID ESTER DERIVATIVES.
SE9203296D0 (en) THE USE OF INOSITOLTRISPHATE FOR THE PREPARING OF MEDICAMENTS
GB9323403D0 (en) Pharmaceuticals